Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH agonist before frozen embryo transfer in endometriosis/adenomyosis
2024-519126-20-00Phase 4Completed
- Sponsor
- Hôpital Foch
- Start
- Nov 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of triptorelin in endometriosis and adenomyosis (2 arms), sponsored by Hôpital Foch. Primary endpoint: Clinical pregnancy rate. Started Nov 2024; status: completed.
02
Drugs
triptorelin
03
Conditions
endometriosisadenomyosis
Beyond the preview
Go deeper on 2024-519126-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519126-20-00.